Kajiyama, Shota
Nagatake, Takahiro
Ishikawa, Satoru
Hosomi, Koji
Shimada, Yuki
Matsui, Yasunori
Kunisawa, Jun
Funding for this research was provided by:
Japan Agency for Medical Research and Development (223fa727001h0001)
Ministry of Health and Welfare of Japan and Public /Private R&D Investment Strategic Expansion PrograM: PRISM (20AC5004)
Article History
Received: 31 October 2022
Accepted: 27 July 2023
First Online: 8 August 2023
Declarations
:
: All experiments involving animals were conducted with the approval of the animal experimentation ethics committees of Kobayashi Pharmaceutical Co., Ltd., and according to the animal experimentation ethics guidelines of Kobayashi Pharmaceutical Co., Ltd. and NIBIOHN. Our manuscript reporting adheres to the ARRIVE guidelines ().
: Not applicable.
: The authors declare no competing interests.